Exosomes

Global Market Trajectory & Analytics

MCP11886

EXECUTIVE ENGAGEMENTS

POOL

1838
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

331
Interactions with Platform & by Email

PARTICIPANTS

74
Unique # Participated

VALIDATIONS

16
Responses Validated*

COMPANIES

46
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

72

PAGES

148

EDITION

6

PRICE

USD 4950

CODE

MCP11886


COMPETITIVE METRICS

COMPANY

D S N T

% *

AcouSort

Aegle Therapeutics

Alxerion Biotech

Anjarium Biosciences

Aruna Biomedical

Avalon GloboCare Corp

BreStem Therapeutics

Capricor Therapeutics, Inc.

Cell Care Therapeutics

Ciloa

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Exosomes estimated at US$334.6 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at aCAGR of 18.4% over the period 2020-2027. Isolation Methods, one of the segments analyzed in the report, is projected to record 16.8% CAGR and reach US$579.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Downstream Analysis segment is readjusted to a revised 20.5% CAGR for the next 7-year period.
The Exosomes market in the U.S. is estimated at US$99.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$189.8 Million by the year 2027 trailing a CAGR of 17.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.6% and 16% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.6% CAGR.

SELECT PLAYERS

Danaher Corporation; Diagenode SA; FUJIFILM Holdings Corporation; Hitachi Chemical Co America Ltd.; Lonza Group Ltd.; MBL International Corporation; Miltenyi Biotec GmbH; Novus Biologicals LLC; QIAGEN GmbH; Thermo Fisher Scientific, Inc.

SEGMENTS

» Application (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, Other Applications) » Workflow (Isolation Methods, Downstream Analysis)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Exosomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Exosomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Isolation Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Isolation Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Downstream Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Downstream Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Neurodegenerative diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Neurodegenerative diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Cardiovascular diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Cardiovascular diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Infectious diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Infectious diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Exosomes by Workflow - Isolation Methods and Downstream Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Exosomes by Workflow - Percentage Breakdown of Value Sales for Isolation Methods and Downstream Analysis for the Years 2020 & 2027
USA Current & Future Analysis for Exosomes by Application - Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Exosomes by Application - Percentage Breakdown of Value Sales for Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Exosomes by Workflow - Isolation Methods and Downstream Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Exosomes by Workflow - Percentage Breakdown of Value Sales for Isolation Methods and Downstream Analysis for the Years 2020 & 2027
Canada Current & Future Analysis for Exosomes by Application - Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Exosomes by Application - Percentage Breakdown of Value Sales for Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Exosomes by Workflow - Isolation Methods and Downstream Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Exosomes by Workflow - Percentage Breakdown of Value Sales for Isolation Methods and Downstream Analysis for the Years 2020 & 2027
Japan Current & Future Analysis for Exosomes by Application - Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Exosomes by Application - Percentage Breakdown of Value Sales for Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Exosomes by Workflow - Isolation Methods and Downstream Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Exosomes by Workflow - Percentage Breakdown of Value Sales for Isolation Methods and Downstream Analysis for the Years 2020 & 2027
China Current & Future Analysis for Exosomes by Application - Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Exosomes by Application - Percentage Breakdown of Value Sales for Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Exosomes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Exosomes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Exosomes by Workflow - Isolation Methods and Downstream Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Exosomes by Workflow - Percentage Breakdown of Value Sales for Isolation Methods and Downstream Analysis for the Years 2020 & 2027
Europe Current & Future Analysis for Exosomes by Application - Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Exosomes by Application - Percentage Breakdown of Value Sales for Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Exosomes by Workflow - Isolation Methods and Downstream Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Exosomes by Workflow - Percentage Breakdown of Value Sales for Isolation Methods and Downstream Analysis for the Years 2020 & 2027
France Current & Future Analysis for Exosomes by Application - Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Exosomes by Application - Percentage Breakdown of Value Sales for Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Exosomes by Workflow - Isolation Methods and Downstream Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Exosomes by Workflow - Percentage Breakdown of Value Sales for Isolation Methods and Downstream Analysis for the Years 2020 & 2027
Germany Current & Future Analysis for Exosomes by Application - Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Exosomes by Application - Percentage Breakdown of Value Sales for Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Exosomes by Workflow - Isolation Methods and Downstream Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Exosomes by Workflow - Percentage Breakdown of Value Sales for Isolation Methods and Downstream Analysis for the Years 2020 & 2027
Italy Current & Future Analysis for Exosomes by Application - Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Exosomes by Application - Percentage Breakdown of Value Sales for Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Exosomes by Workflow - Isolation Methods and Downstream Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Exosomes by Workflow - Percentage Breakdown of Value Sales for Isolation Methods and Downstream Analysis for the Years 2020 & 2027
UK Current & Future Analysis for Exosomes by Application - Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Exosomes by Application - Percentage Breakdown of Value Sales for Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Exosomes by Workflow - Isolation Methods and Downstream Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Exosomes by Workflow - Percentage Breakdown of Value Sales for Isolation Methods and Downstream Analysis for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Exosomes by Application - Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Exosomes by Application - Percentage Breakdown of Value Sales for Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Exosomes by Workflow - Isolation Methods and Downstream Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Exosomes by Workflow - Percentage Breakdown of Value Sales for Isolation Methods and Downstream Analysis for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Exosomes by Application - Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Exosomes by Application - Percentage Breakdown of Value Sales for Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Exosomes by Workflow - Isolation Methods and Downstream Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Exosomes by Workflow - Percentage Breakdown of Value Sales for Isolation Methods and Downstream Analysis for the Years 2020 & 2027
Rest of World Current & Future Analysis for Exosomes by Application - Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Exosomes by Application - Percentage Breakdown of Value Sales for Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Other Applications for the Years 2020 & 2027
Total Companies Profiled: 46

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com